Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1996 May;74(3):F182–F186. doi: 10.1136/fn.74.3.f182

Factors related to transfusion in very low birthweight infants treated with erythropoietin.

R F Maier 1, M Obladen 1, D Messinger 1, C A Wardrop 1
PMCID: PMC2528356  PMID: 8777681

Abstract

The need for red cell transfusions is reduced but not eliminated by recombinant human erythropoietin (rhEPO) in very low birthweight (VLBW) infants. To detect factors associated with the decision to transfuse VLBW infants during rhEPO treatment and to explain rhEPO 'non-responders', the subgroup of those 120 VLBW infants who were treated with rhEPO 750 IU/kg per week in the second European Multicentre rhEPO Trial was evaluated. Sixty (50%) infants received at least one transfusion during erythropoietin treatment. Transfusion was frequent in infants with extremely low birthweight (79% for 750-999 g), low gestational age (70% for < or = 28 weeks), low initial haematocrit or low initial reticulocyte count (61% for haematocrit < or = 0.48 and reticulocytes < or = 9%, respectively). Considerable differences among centres were found for sampling blood loss, iron supply, and transfusion rate, which ranged from 13% to 73% and was related to the volume of diagnostic blood loss (19% vs 80% for blood loss < 1 vs > or = 1 ml/kg per day). The prognostic variables birthweight, initial haematocrit, and gestational age were found to be most predictive for transfusion. To improve rhEPO response in VLBW infants, there is a need to minimise diagnostic blood loss, to prevent iron deficiency, and to develop rational criteria for transfusion in preterm infants.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakris G. L., Sauter E. R., Hussey J. L., Fisher J. W., Gaber A. O., Winsett R. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. N Engl J Med. 1990 Jul 12;323(2):86–90. doi: 10.1056/NEJM199007123230203. [DOI] [PubMed] [Google Scholar]
  2. Bechensteen A. G., Hågå P., Halvorsen S., Whitelaw A., Liestøl K., Lindemann R., Grøgaard J., Hellebostad M., Saugstad O. D., Grønn M. Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity. Arch Dis Child. 1993 Jul;69(1 Spec No):19–23. doi: 10.1136/adc.69.1_spec_no.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beck D., Masserey E., Meyer M., Calame A. Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity. Eur J Pediatr. 1991 Sep;150(11):767–772. doi: 10.1007/BF02026707. [DOI] [PubMed] [Google Scholar]
  4. Brown M. S., Berman E. R., Luckey D. Prediction of the need for transfusion during anemia of prematurity. J Pediatr. 1990 May;116(5):773–778. doi: 10.1016/s0022-3476(05)82670-8. [DOI] [PubMed] [Google Scholar]
  5. Brown M. S., Phipps R. H., Dallman P. R. Postnatal changes in fetal hemoglobin, oxygen affinity and 2,3-diphosphoglycerate in previously transfused preterm infants. Biol Neonate. 1985;48(2):70–76. doi: 10.1159/000242156. [DOI] [PubMed] [Google Scholar]
  6. Brugnara C., Chambers L. A., Malynn E., Goldberg M. A., Kruskall M. S. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood. 1993 Feb 15;81(4):956–964. [PubMed] [Google Scholar]
  7. Carnielli V., Montini G., Da Riol R., Dall'Amico R., Cantarutti F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr. 1992 Jul;121(1):98–102. doi: 10.1016/s0022-3476(05)82552-1. [DOI] [PubMed] [Google Scholar]
  8. Emmerson A. J., Coles H. J., Stern C. M., Pearson T. C. Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child. 1993 Mar;68(3 Spec No):291–296. doi: 10.1136/adc.68.3_spec_no.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gonzalez M. T., Sherwood J. B., Brion L. P., Schulman M. Erythropoietin levels during theophylline treatment in premature infants. J Pediatr. 1994 Jan;124(1):128–130. doi: 10.1016/s0022-3476(94)70268-3. [DOI] [PubMed] [Google Scholar]
  10. Halpérin D. S., Wacker P., Lacourt G., Félix M., Babel J. F., Aapro M., Wyss M. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr. 1990 May;116(5):779–786. doi: 10.1016/s0022-3476(05)82671-x. [DOI] [PubMed] [Google Scholar]
  11. Holland B. M., Jones J. G., Wardrop C. A. Lessons from the anemia of prematurity. Hematol Oncol Clin North Am. 1987 Sep;1(3):355–366. [PubMed] [Google Scholar]
  12. Kientsch-Engel R., Hallermayer K., Dessauer A. Methods for measuring erythropoietin and erythropoietin antibodies using ELISA technique. Contrib Nephrol. 1989;76:100–105. doi: 10.1159/000417885. [DOI] [PubMed] [Google Scholar]
  13. Kinmond S., Aitchison T. C., Holland B. M., Jones J. G., Turner T. L., Wardrop C. A. Umbilical cord clamping and preterm infants: a randomised trial. BMJ. 1993 Jan 16;306(6871):172–175. doi: 10.1136/bmj.306.6871.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kivivuori S. M., Heikinheimo M., Teppo A. M., Siimes M. A. Early rise in serum concentration of transferrin receptor induced by recombinant human erythropoietin in very-low-birth-weight infants. Pediatr Res. 1994 Jul;36(1 Pt 1):85–89. doi: 10.1203/00006450-199407001-00015. [DOI] [PubMed] [Google Scholar]
  15. Kivivuori S. M., Järvenpä A. L., Salmenperä L., Viinikka L., Siimes M. A. Erythropoiesis of very low-birth-weight infants dependent on prenatal growth rate and protein status. Acta Paediatr. 1994 Jan;83(1):13–18. doi: 10.1111/j.1651-2227.1994.tb12944.x. [DOI] [PubMed] [Google Scholar]
  16. Levy G. J., Strauss R. G., Hume H., Schloz L., Albanese M. A., Blazina J., Werner A., Sotelo-Avila C., Barrasso C., Blanchette V. National survey of neonatal transfusion practices: I. Red blood cell therapy. Pediatrics. 1993 Mar;91(3):523–529. [PubMed] [Google Scholar]
  17. Maier R. F., Obladen M., Scigalla P., Linderkamp O., Duc G., Hieronimi G., Halliday H. L., Versmold H. T., Moriette G., Jorch G. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med. 1994 Apr 28;330(17):1173–1178. doi: 10.1056/NEJM199404283301701. [DOI] [PubMed] [Google Scholar]
  18. Messer J., Haddad J., Donato L., Astruc D., Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics. 1993 Oct;92(4):519–523. [PubMed] [Google Scholar]
  19. Meyer M. P., Meyer J. H., Commerford A., Hann F. M., Sive A. A., Moller G., Jacobs P., Malan A. F. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics. 1994 Jun;93(6 Pt 1):918–923. [PubMed] [Google Scholar]
  20. Obladen M., Maier R., Segerer H., Grauel E. L., Holland B. M., Stewart G., Jorch G., Rabe H., Linderkamp O., Hoffmann H. G. Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial. Contrib Nephrol. 1991;88:314–326. doi: 10.1159/000419541. [DOI] [PubMed] [Google Scholar]
  21. Obladen M., Sachsenweger M., Stahnke M. Blood sampling in very low birth weight infants receiving different levels of intensive care. Eur J Pediatr. 1988 May;147(4):399–404. doi: 10.1007/BF00496419. [DOI] [PubMed] [Google Scholar]
  22. Ohls R. K., Christensen R. D. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr. 1991 Nov;119(5):781–788. doi: 10.1016/s0022-3476(05)80303-8. [DOI] [PubMed] [Google Scholar]
  23. Ohls R. K., Osborne K. A., Christensen R. D. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial. J Pediatr. 1995 Mar;126(3):421–426. doi: 10.1016/s0022-3476(95)70462-0. [DOI] [PubMed] [Google Scholar]
  24. Okano M., Ohnota H., Sasaki R. Protein deficiency impairs erythropoiesis in rats by reducing serum erythropoietin concentration and the population size of erythroid precursor cells. J Nutr. 1992 Jul;122(7):1376–1383. doi: 10.1093/jn/122.7.1376. [DOI] [PubMed] [Google Scholar]
  25. Shannon K. M., Keith J. F., 3rd, Mentzer W. C., Ehrenkranz R. A., Brown M. S., Widness J. A., Gleason C. A., Bifano E. M., Millard D. D., Davis C. B. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics. 1995 Jan;95(1):1–8. [PubMed] [Google Scholar]
  26. Shannon K. M., Mentzer W. C., Abels R. I., Freeman P., Newton N., Thompson D., Sniderman S., Ballard R., Phibbs R. H. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr. 1991 Jun;118(6):949–955. doi: 10.1016/s0022-3476(05)82217-6. [DOI] [PubMed] [Google Scholar]
  27. Shannon K. M., Mentzer W. C., Abels R. I., Wertz M., Thayer-Moriyama J., Li W. Y., Thompson D., Decelle S., Phibbs R. H. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study. J Pediatr. 1992 Apr;120(4 Pt 1):586–592. doi: 10.1016/s0022-3476(05)82488-6. [DOI] [PubMed] [Google Scholar]
  28. Soubasi V., Kremenopoulos G., Diamandi E., Tsantali C., Tsakiris D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatr Res. 1993 Nov;34(5):675–679. doi: 10.1203/00006450-199311000-00022. [DOI] [PubMed] [Google Scholar]
  29. Strauss R. G. Transfusion therapy in neonates. Am J Dis Child. 1991 Aug;145(8):904–911. doi: 10.1001/archpedi.1991.02160080082025. [DOI] [PubMed] [Google Scholar]
  30. Wardrop C. A., Holland B. M., Jacobs S., Jones J. G. Optimization of the blood for oxygen transport and tissue perfusion in critical care. Postgrad Med J. 1992;68 (Suppl 2):S2–S6. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES